Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
miglustat — UDP-glucose ceramide glucosyltransferase Interaction
Drug-target interaction between miglustat and UDP-glucose ceramide glucosyltransferase. Synthetic organic pharmacological agent targeting this protein.
milnacipran — NET Interaction
Drug-target interaction between milnacipran and NET. Synthetic organic pharmacological agent targeting this protein.
milnacipran — SERT Interaction
Drug-target interaction between milnacipran and SERT. Synthetic organic pharmacological agent targeting this protein.
milrinone — phosphodiesterase 3A Interaction
Drug-target interaction between milrinone and phosphodiesterase 3A. Synthetic organic pharmacological agent targeting this protein.
mirabegron — β3-adrenoceptor Interaction
Drug-target interaction between mirabegron and β3-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
mirdametinib — mitogen-activated protein kinase kinase 1 Interaction
Drug-target interaction between mirdametinib and mitogen-activated protein kinase kinase 1. Synthetic organic pharmacological agent targeting this protein.
mirtazapine — α2A-adrenoceptor Interaction
Drug-target interaction between mirtazapine and α2A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
mirtazapine — α2B-adrenoceptor Interaction
Drug-target interaction between mirtazapine and α2B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
mirtazapine — α2C-adrenoceptor Interaction
Drug-target interaction between mirtazapine and α2C-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
mirtazapine — 5-HT2A receptor Interaction
Drug-target interaction between mirtazapine and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
mirtazapine — 5-HT2C receptor Interaction
Drug-target interaction between mirtazapine and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
misoprostol (methyl ester) — EP3 receptor Interaction
Drug-target interaction between misoprostol (methyl ester) and EP3 receptor. Synthetic organic pharmacological agent targeting this protein.
mizolastine — H1 receptor Interaction
Drug-target interaction between mizolastine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
moclobemide — Monoamine oxidase A Interaction
Drug-target interaction between moclobemide and Monoamine oxidase A. Synthetic organic pharmacological agent targeting this protein.
moexipril — Angiotensin-converting enzyme Interaction
Drug-target interaction between moexipril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
mogamulizumab — CCR4 Interaction
Drug-target interaction between mogamulizumab and CCR4. Antibody pharmacological agent targeting this protein.
molindone — 5-HT2A receptor Interaction
Drug-target interaction between molindone and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
momelotinib — Janus kinase 1 Interaction
Drug-target interaction between momelotinib and Janus kinase 1. Synthetic organic pharmacological agent targeting this protein.
momelotinib — Janus kinase 2 Interaction
Drug-target interaction between momelotinib and Janus kinase 2. Synthetic organic pharmacological agent targeting this protein.
mometasone — Glucocorticoid receptor Interaction
Drug-target interaction between mometasone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
montelukast — CysLT1 receptor Interaction
Drug-target interaction between montelukast and CysLT1 receptor. Synthetic organic pharmacological agent targeting this protein.
morphine — μ receptor Interaction
Drug-target interaction between morphine and μ receptor. Natural product pharmacological agent targeting this protein.
moxetumomab pasudotox — CD22 Interaction
Drug-target interaction between moxetumomab pasudotox and CD22. Antibody pharmacological agent targeting this protein.
muromonab-CD3 — CD3e Interaction
Drug-target interaction between muromonab-CD3 and CD3e. Antibody pharmacological agent targeting this protein.
mycophenolate mofetil — inosine monophosphate dehydrogenase 1 Interaction
Drug-target interaction between mycophenolate mofetil and inosine monophosphate dehydrogenase 1. Synthetic organic pharmacological agent targeting this protein.
mycophenolate mofetil — inosine monophosphate dehydrogenase 2 Interaction
Drug-target interaction between mycophenolate mofetil and inosine monophosphate dehydrogenase 2. Synthetic organic pharmacological agent targeting this protein.
mycophenolic acid — inosine monophosphate dehydrogenase 1 Interaction
Drug-target interaction between mycophenolic acid and inosine monophosphate dehydrogenase 1. Natural product pharmacological agent targeting this protein.
mycophenolic acid — inosine monophosphate dehydrogenase 2 Interaction
Drug-target interaction between mycophenolic acid and inosine monophosphate dehydrogenase 2. Natural product pharmacological agent targeting this protein.
N-methyl scopolamine — M1 receptor Interaction
Drug-target interaction between N-methyl scopolamine and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
N-methyl scopolamine — M3 receptor Interaction
Drug-target interaction between N-methyl scopolamine and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
nadolol — β1-adrenoceptor Interaction
Drug-target interaction between nadolol and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
nadolol — β2-adrenoceptor Interaction
Drug-target interaction between nadolol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
nafamostat — complement C1r Interaction
Drug-target interaction between nafamostat and complement C1r. Synthetic organic pharmacological agent targeting this protein.
nafamostat — serine protease 1 Interaction
Drug-target interaction between nafamostat and serine protease 1. Synthetic organic pharmacological agent targeting this protein.
nafamostat — tryptase alpha/beta 1 Interaction
Drug-target interaction between nafamostat and tryptase alpha/beta 1. Synthetic organic pharmacological agent targeting this protein.
nafarelin — GnRH1 receptor Interaction
Drug-target interaction between nafarelin and GnRH1 receptor. Peptide pharmacological agent targeting this protein.
nalbuphine — δ receptor Interaction
Drug-target interaction between nalbuphine and δ receptor. Synthetic organic pharmacological agent targeting this protein.
nalbuphine — κ receptor Interaction
Drug-target interaction between nalbuphine and κ receptor. Synthetic organic pharmacological agent targeting this protein.
nalbuphine — μ receptor Interaction
Drug-target interaction between nalbuphine and μ receptor. Synthetic organic pharmacological agent targeting this protein.
naldemedine — μ receptor Interaction
Drug-target interaction between naldemedine and μ receptor. Synthetic organic pharmacological agent targeting this protein.
nalmefene — κ receptor Interaction
Drug-target interaction between nalmefene and κ receptor. Synthetic organic pharmacological agent targeting this protein.
nalmefene — μ receptor Interaction
Drug-target interaction between nalmefene and μ receptor. Synthetic organic pharmacological agent targeting this protein.
nalorphine — μ receptor Interaction
Drug-target interaction between nalorphine and μ receptor. Synthetic organic pharmacological agent targeting this protein.
naloxone — δ receptor Interaction
Drug-target interaction between naloxone and δ receptor. Synthetic organic pharmacological agent targeting this protein.
naloxone — κ receptor Interaction
Drug-target interaction between naloxone and κ receptor. Synthetic organic pharmacological agent targeting this protein.
naltrexone — δ receptor Interaction
Drug-target interaction between naltrexone and δ receptor. Synthetic organic pharmacological agent targeting this protein.
naltrexone — κ receptor Interaction
Drug-target interaction between naltrexone and κ receptor. Synthetic organic pharmacological agent targeting this protein.
naltrexone — μ receptor Interaction
Drug-target interaction between naltrexone and μ receptor. Synthetic organic pharmacological agent targeting this protein.
nandrolone — Androgen receptor Interaction
Drug-target interaction between nandrolone and Androgen receptor. Synthetic organic pharmacological agent targeting this protein.
naproxen — COX-1 Interaction
Drug-target interaction between naproxen and COX-1. Synthetic organic pharmacological agent targeting this protein.
naproxen — COX-2 Interaction
Drug-target interaction between naproxen and COX-2. Synthetic organic pharmacological agent targeting this protein.
naratriptan — 5-HT1B receptor Interaction
Drug-target interaction between naratriptan and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.
naratriptan — 5-HT1D receptor Interaction
Drug-target interaction between naratriptan and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.
narsoplimab — MBL associated serine protease 2 Interaction
Drug-target interaction between narsoplimab and MBL associated serine protease 2. Antibody pharmacological agent targeting this protein.
natalizumab — integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor) Interaction
Drug-target interaction between natalizumab and integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor). Antibody pharmacological agent targeting this protein.
navepegritide — Guanylyl cyclase-B Interaction
Drug-target interaction between navepegritide and Guanylyl cyclase-B. Peptide pharmacological agent targeting this protein.
necitumumab — epidermal growth factor receptor Interaction
Drug-target interaction between necitumumab and epidermal growth factor receptor. Antibody pharmacological agent targeting this protein.
nefazodone — 5-HT2A receptor Interaction
Drug-target interaction between nefazodone and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
nefazodone — NET Interaction
Drug-target interaction between nefazodone and NET. Synthetic organic pharmacological agent targeting this protein.
nefazodone — SERT Interaction
Drug-target interaction between nefazodone and SERT. Synthetic organic pharmacological agent targeting this protein.